Co prescription of anti-acid therapy reduces the bioavailability of mycophenolate mofetil in systemic sclerosis patients: A crossover trial
Glaxon Alex, KC Shanoj, Delcey Rachel Varghese, AS Sageer Babu, Reshma Reji, Padmanabha Shenoy
Topics & Concepts
MedicineEsomeprazoleMycophenolic acidMycophenolateBioavailabilityGastroenterologyRanitidinePharmacokineticsCrossover studyInternal medicinePharmacologyArea under the curveTransplantationPathologyAlternative medicinePlaceboSystemic Sclerosis and Related DiseasesInflammatory Myopathies and DermatomyositisInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis